Iveena
iVeena Delivery Systems, Inc. is a privately held, clinical stage ophthalmology company developing disease-modifying pharmacologic innovations for refractive diseases. iVeena has licensed its lead asset to Glaukos Corporation, IVMED-80, an Orphan Drug Designated eye drop for keratoconus. iVeena is developing IVMED-85, a first-in-class, investigational eyedrop formulation for pediatric myopia. The company’s lead programs comprise of novel proprietary products; IVMED-80 for keratoconus and IVMED-85 for myopia.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
70
organic / mo
Sign up free to see all 2 verified contacts at Iveena
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- MB
Mike Burr
Vice President Product Development · Sales & Business Development
EmailPhone - RH
Ron Heffernan
Board Member & Chair of Audit Committee · General Business & Management
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Iveena
2 distinct titles indexed · top 2 shown.
- 1board member & chair of audit committee
- 1vice president product development
Sign up to unlock all 2 contacts at Iveena
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Iveena
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.